Inspira Technologies OXY B.H.N. Ltd. (IINN) Stock Analysis & Investment Frameworks
Inspira Technologies OXY B.H.N. Ltd. (IINN) stock analysis on Invetso. Review Inspira Technologies OXY B.H.N. Ltd.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Inspira Technologies OXY B.H.N. Ltd. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Devices
- Country: IL
Inspira Technologies OXY B.H.N. Ltd. Key Financial Metrics
- Market Cap: $25.29M
- Revenue: $289000.00
- ROE: -397.89%
- ROIC: -326.40%
- Dividend Yield: N/A
About Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.